| 产品描述: | Chk1-IN-6 is a selective and orally active Chk1 inhibitor with an IC50 of 16.1 nM. Chk1-IN-6 shows antiproliferative activity of MV-4-11 cells. Chk1-IN-6 exerts effective response in the MV-4-11 xenograft mouse model. Chk1-IN-6 exhibits synergistic anticancer effect with Gemcitabine . Chk1-IN-6 can be used in the research of cancers such as acute myeloid leukemia and colorectal adenocarcinoma. |
| 靶点: |
Chk1:16.1 nM (IC50) |
| 体内研究: |
Chk1-IN-6 (Compound 6c) 对 MV-4-11 和 Z138 细胞表现出抗增殖活性,IC50 值分别为 0.14 和 3.28 μM。 Chk1-IN-6 (0-5 nM,72 小时) 与 Gemcitabine 联合使用,对 HT-29、A549 和 RPMI-8226 细胞表现出协同作用。 Chk1-IN-6 (0-800 nM,2 小时) 在 MV-4-11 细胞中抑制磷酸化的 S296 CHK1 (pS296 CHK1) ,并诱导磷酸化的 S345 CHK1 (pS345 CHK1)。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.737 ml |
13.685 ml |
27.37 ml |
| 5 mM |
0.547 ml |
2.737 ml |
5.474 ml |
| 10 mM |
0.274 ml |
1.369 ml |
2.737 ml |
| 50 mM |
0.055 ml |
0.274 ml |
0.547 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |